January 9, 2024
The new EQT Healthcare Growth Strategy builds on EQT’s 30-year healthcare track record and will focus on scaling innovative, fast-growing healthcare companies to help deliver positive outcomes across the value chain By helping companies build commercial muscle and expand their global reach, the Strategy aims to enable the development of medical research, diagnostics, tools and [...]
Bio-Link and Verdot Forge Strategic Partnership to Advance Bioprocessing Technologies in China
January 8, 2024
Bio-Link, a prominent Chinese bioprocessing company, and the French downstream bioprocessing company Verdot signed a strategic partnership agreement that marks a significant step forward in the field of biopharmaceutical manufacturing. The collaboration will see Bio-Link become the major distributor for Verdot’s innovative chromatography columns in the Chinese market. The partnership was facilitated by Cathay Capital [...]
New developments at Evosep to make clinical proteomics 100x more robust and 10x faster
January 8, 2024
Thermo Fisher and Evosep develop and promote robust high-throughput workflows for clinical proteomics ODENSE, Denmark -- Evosep, a leading provider of sample preparation solutions for mass spectrometry-based proteomics, today announced a co-marketing agreement with Thermo Fisher Scientific, a world leader in serving science. This collaboration marks a significant milestone in advancing clinical proteomics research by combining Evosep's cutting-edge [...]
Devyser signs in vitro diagnostic agreement with Illumina to broaden access to its tests
January 8, 2024
Devyser Diagnostics AB has entered an in vitro diagnostic development agreement with Illumina, Inc. (Nasdaq: ILMN). The agreement enables Devyser to develop and offer its in vitro diagnostic (IVD) tests on Illumina MiSeqDx next-generation sequencing (NGS) instrument in the United States and Europe. The IVD development agreement allows Devyser to perform regulatory registrations of its [...]
January 8, 2024
MENLO PARK, Calif. – Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced a research collaboration with NVIDIA to accelerate the development and adoption of advanced computer vision solutions in life sciences. Deepcell, which already uses the NVIDIA A4000 and NVIDIA AI technology, will incorporate NVIDIA AI into its [...]
ThinkCyte Launches Partnering Platform
January 8, 2024
Tokyo, Japan -- ThinkCyte today announced the launch of its new partnering program for the biopharmaceutical and diagnostics industry. The program is designed to help accelerate research and development of novel therapeutics and artificial intelligence (AI)-based approaches in life science. The program consists of three strategic arms; the Disease Profiling Platform, Platform, the Biopharma Platform, [...]
Nanologica Delivers Silica to Customer in China to a Value of TSEK 930
January 8, 2024
Nanologica's Chinese distributor Yunbo Technology has made another call-off against the agreement previously signed for the delivery of silica worth USD 14 million over a six-year period. This call-off amounts to approximately SEK 930 thousand. The delivery is the fourth that Nanologica has made since the company approved its silica-based media for preparative chromatography, NLAB [...]
Pleno Deploys its RAPTOR Instrument Platform Available with TotalSeq™ Antibodies from BioLegend
January 8, 2024
The integration seeks to enable multi-omic biomarker detection at unprecedented speed, scale, and cost SAN DIEGO -- Pleno Inc., a multi-omic instrument platform company revolutionizing biological target detection for clinical testing and biomedical research, today announced successful deployment of the first of its RAPTOR instruments integrated with industry-leading TotalSeq™ antibodies from BioLegend, part of Revvity. This marks the [...]
Scitara and Waters to provide robust lab connectivity and data management
January 8, 2024
Marlborough, MA – Scitara, a market-leading innovator in laboratory digital transformation, has announced an agreement with Waters Corporation (NYSE: WAT), a global leader in analytical instruments and software. Under the agreement, Waters has licensed Scitara’s Digital Lab Exchange DLX™ cloud platform to communicate with Waters’ Empower™ Chromatography Data System and waters_connect™ Lab Informatics Platform to [...]
Exactis Innovation and SOPHiA GENETICS Announce Collaboration on Multimodal Data Analytics
January 8, 2024
Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced a collaboration with Exactis Innovation, based in Montreal, Quebec, who will contribute to cancer research and data-driven decision-making through SOPHiA GENETICS’ multimodal real-world data offering. Exactis Innovation is a non-profit network of hospital partners across Canada dedicated [...]

